FDA approves first oral antiviral to treat adult patients with COVID-19
The US Food and Drug Administration (FDA) has announced that it has approved the oral antiviral Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of adult patients with mild-to-moderate COVID-19 if they are at high risk for progression to severe COVID-19, including hospitalisation or death.
The approval of Paxlovid marks the fourth approval of a drug to treat COVID-19 in adults, although this is the first oral antiviral pill to be approved for this indication. […]
